Trials / Conditions / P53 Mutation
P53 Mutation
6 registered clinical trials studyying P53 Mutation.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer NCT04159155 | University Health Network, Toronto | Phase 2 / Phase 3 |
| Unknown | Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations NCT04906031 | First Affiliated Hospital of Jinan University | Phase 2 |
| Active Not Recruiting | A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas NCT03611868 | Ascentage Pharma Group Inc. | Phase 1 / Phase 2 |
| Withdrawn | Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS) NCT03377725 | Li Junmin | Phase 3 |
| Unknown | Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations NCT03381781 | Li Junmin | Phase 2 |
| Unknown | Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS NCT03855371 | Ruijin Hospital | Phase 1 |